Product subscriptions are not the same as dermatology review
Many online skincare companies start with a quiz and quickly move toward a product bundle or recurring subscription. That may be convenient, but convenience alone does not answer the clinical question: what condition is actually present?
The American Academy of Dermatology says telemedicine visits should provide access to quality care from a licensed physician or board-certified dermatologist and that patients should know who is providing their care.
Diagnosis changes the plan
Acne, rosacea, melasma, post-inflammatory hyperpigmentation, seborrheic dermatitis, contact dermatitis, hair loss, and texture concerns can overlap. The same "brightening" or "anti-acne" product may be wrong for several of those situations.
The American Academy of Dermatology teledermatology standards emphasize that adequate and relevant history should be obtained before diagnosis and treatment planning.
Why product-first care can disappoint patients
Patients often arrive after trying multiple products, cycling through actives, or reacting to strong skincare. They may assume treatment failed because their skin is "stubborn," when the real problem is that the diagnosis or treatment target was wrong.
For example, acne-like bumps could be acne, rosacea, folliculitis, dermatitis, or irritation. Pigment could be melasma, post-inflammatory hyperpigmentation, sun damage, or another pattern. Hair loss could be androgenetic alopecia, shedding, traction, autoimmune disease, or scarring alopecia.
How CutisRx is different
CutisRx is intended to be a clinical pathway first. Patients start with the concern, complete the intake, provide photos when appropriate, and receive board-certified dermatology review when clinically appropriate. Treatment comes after review, not before.
That is the main difference: CutisRx is not trying to make every patient fit the same product routine.
Available in eligible U.S. states except Alaska, Mississippi, and New Jersey.
FAQ
Is CutisRx just a skincare subscription?
No. CutisRx is positioned as a diagnosis-first teledermatology pathway with treatment recommendations when clinically appropriate, not a product quiz built around selling the same routine to everyone.
Why does diagnosis matter if I already know my concern?
Patients may know their concern, such as acne, redness, pigment, hair loss, or texture. The clinical question is what pattern is causing it and what treatment approach is appropriate.
Does teledermatology replace in-person dermatology?
No. Some concerns can be reviewed online, while others require in-person evaluation, urgent care, procedures, labs, or biopsy.